Trial reportBehaviour research and therapy2016
Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well?
Trial report in Behaviour research and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Motivation in the Bergen 4-day treatment for obsessive-compulsive disorder.BMC psychiatry · 2025Trial
- Examining the Role of Homework Compliance in Acceptance-Enhanced Behavior Therapy for Trichotillomania.Behavior therapy · 2025Trial
- Behavioral avoidance predicts treatment outcome with exposure and response prevention for obsessive-compulsive disorder.Depression and anxiety · 2018Trial
- Trauma-Related Compulsions in Obsessive-Compulsive Disorder: Functional Insights From Factor Analysis.Stress and health : journal of the International Society for the Investigation of Stress · 2026Article
- Beating OCD and Learning Digitally (BOLD): an open trial of a therapist-supported, self-guided exposure and response prevention app for adults with OCD.Cognitive behaviour therapy · 2026Article
- Characterizing and predicting refractory rumination in obsessive compulsive disorder.Journal of affective disorders · 2026Article
- Value, development challenges, and strategies for gaining internal endorsement of digitally connected subcutaneous drug delivery devices: a survey of pharmaceutical stakeholders.Frontiers in digital health · 2026Article
- A network analysis of how obsessive-compulsive symptoms change during exposure and response prevention treatment.Psychological medicine · 2025Article
- Addressing co-occurring conditions in behavioural therapy for tic disorders: a review and guideline.European child & adolescent psychiatry · 2024Review
- Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder.BMC psychiatry · 2024Article
- Predictors of EX/RP alone versus EX/RP with medication for adults with OCD: does medication status moderate outcomes?Journal of obsessive-compulsive and related disorders · 2023Article
- Common rituals in obsessive-compulsive disorder and implications for treatment: A mixed-methods study.Psychological assessment · 2023Article
- Mechanisms of exposure and response prevention in obsessive-compulsive disorder: effects of habituation and expectancy violation on short-term outcome in cognitive behavioral therapy.BMC psychiatry · 2022Article
- Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.Behaviour research and therapy · 2021Article
- Homework adherence predicts therapeutic improvement from behavior therapy in Tourette's disorder.Behaviour research and therapy · 2021Article
- Treatment Adherence as Predictor of Outcome in Concentrated Exposure Treatment for Obsessive-Compulsive Disorder.Frontiers in psychiatry · 2021Article
- Innovations in the Delivery of Exposure and Response Prevention for Obsessive-Compulsive Disorder.Current topics in behavioral neurosciences · 2021Article
- Long-term Outcomes of Intensive Inpatient Care for Severe, Resistant Obsessive-Compulsive Disorder: Résultats à long terme de soins intensifs à des patients hospitalisés pour un trouble obsessionnel-compulsif grave et résistant.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2020Article
- Effectiveness of a Participatory and Interactive Virtual Reality Intervention in Patients With Social Anxiety Disorder: Longitudinal Questionnaire Study.Journal of medical Internet research · 2020Article
- Obsessive-compulsive disorder.Nature reviews. Disease primers · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Exposure and response prevention (EX/RP) is an evidence-based treatment for obsessive-compulsive disorder (OCD), yet not all patients achieve wellness with EX/RP. The degree to which patients adhere to EX/RP procedures outside of sessions has been found to predict therapy outcomes, including who achieves post-treatment wellness. We sought to investigate which components of treatment adherence most relate to outcome and to develop adherence benchmarks to identify who does and does not become well to provide clinicians with prognostic tools. Adherence data came from 37 adult patients with DSM-IV OCD who received 17 sessions of EX/RP as part of a randomized controlled trial of augmentation strategies for incomplete response to serotonin reuptake inhibitors (SRIs). Therapists rated between-session patient adherence at each exposure session by quantifying: 1) the quantity of homework exposures attempted; 2) the quality of attempted exposures; and 3) the degree of success with response prevention. Each adherence item significantly correlated with post-treatment OCD severity. Success with response prevention proved particularly strongly linked to therapy outcome. Time course analysis of this item accurately identified, relatively early in treatment, who would achieve post-treatment wellness. These data provide an efficient method for differentiating between those patients who will and will not achieve wellness after EX/RP augmentation of SRIs. Limitations and clinical implications of the current findings are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.